MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX)
Organization & Developments: Eagle Pharmaceuticals
Parents
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX)
Children
2015: Main drug candidate "bendamustine" for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma
2015: The FDA also approved Eagle's non-alcohol formulation of the taxane chemo drug docetaxel for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, adenocarcinoma and head and neck cancer.
2017: VA-65--Eagle Pharmaceuticals, Inc.
2018: Eagle Pharmaceuticals: New Clarity On Past Overhangs Reveals Solid Value Opportunity - Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)
Jumps
*Key People: Eagle Pharmaceuticals
Finance & Acquisitions: Eagle Pharmaceuticals